Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
8Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
Bio Green Med Solution, Inc. (BGMS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
13Total relationships
2Distinct source URLs
6High confidence
0.747Average confidence
2026-09-14Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Bio Green Med Solution, Inc. Suppliers
Ticker
Name
Confidence
Evidence
DAVID-E-LAZAR
DAVID-E-LAZAR
92%
On January 2, 2025, the Company entered into a securities purchase agreement with Lazar, pursuant to which he agreed to purchase from the Company, 1,000,000 shares of Series C Convertible Preferred S…
DATUK-DR-DORIS-WONG-SING-EE
DATUK-DR-DORIS-WONG-SING-EE
90%
On February 11, 2025, investor Lazar, who was serving as the Company’s interim Chief Executive Officer and Secretary, entered into a securities purchase agreement (the "Purchase Agreement") with an i…
Bio Green Med Solution, Inc. Customers
Ticker
Name
Confidence
Evidence
CYCLACEL-LIMITED
CYCLACEL-LIMITED
85%
the liquidation of the Company’s wholly-owned United Kingdom subsidiary, Cyclacel Limited
ACTIVIST-INVESTING-LLC
ACTIVIST-INVESTING-LLC
62%
usiness. 4 Table of Contents PART I Item 1. Business The following Business Section contains forward-looking statements. Our actual results could differ materially from those anticipated in these for…
CYCLACEL-PHARMACEUTICALS-INC
CYCLACEL-PHARMACEUTICALS-INC
62%
usiness. 4 Table of Contents PART I Item 1. Business The following Business Section contains forward-looking statements. Our actual results could differ materially from those anticipated in these for…
ROTH-CAPITAL-PARTNERS-LLC
ROTH-CAPITAL-PARTNERS-LLC
62%
e Company was required to compensate Roth Capital Partners, LLC, pursuant to a tail provision contained in an engagement letter entered into on March 14, 2024, in an amount equal to 7.0 % of the aggr…
TETHRA-BIOSCIENCES-INC
TETHRA-BIOSCIENCES-INC
62%
usiness. 4 Table of Contents PART I Item 1. Business The following Business Section contains forward-looking statements. Our actual results could differ materially from those anticipated in these for…
THERMOFISHER-SCIENTIFIC-COMPANY
THERMOFISHER-SCIENTIFIC-COMPANY
62%
ket risks could have a detrimental effect on the availability of sources of funding and our ability to access them in the future. Until we can generate a sufficient amount of product revenue to finan…
Reciprocal relationship from TMO graph: Reciprocal relationship from BGMS graph: ket risks could have a detrimental effect on the availability of sources of funding and our ability to access them in …
XCYTE-THERAPIES-INC
XCYTE-THERAPIES-INC
62%
ket risks could have a detrimental effect on the availability of sources of funding and our ability to access them in the future. Until we can generate a sufficient amount of product revenue to finan…
Bio Green Med Solution, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
BGMS-DEBT-8174
Warrants outstanding: 151773
90%
xbrl warrant detail from xbrl 2025-12-31.
BGMS-DEBT-8175
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
Bio Green Med Solution, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Bio Green Med Solution, Inc..
Bio Green Med Solution, Inc. Ownership
Holder
Name
Confidence
Evidence
BGMS-OWNER-RENAISSANCE-TECHNOLOGIES-LLC
RENAISSANCE TECHNOLOGIES LLC
90%
13F overlay lists RENAISSANCE TECHNOLOGIES LLC as top holder; 9 tracked holders.
Bio Green Med Solution, Inc. Extended Supply Chain Network
